Stock Analysis·← Pickers

NOTV

Inotiv, Inc.

Inotiv, Inc. (NOTV) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 27.6 (oversold), with 0/3 trend checks passing.

Price
$0.08
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
27.6
Oversold
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

NOTV with MA50 and MA200

2.361.771.180.600.0107/2110/1401/0904/0707/02
NOTV2025-07-212026-07-02
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.19-94.13% vs price
MA200
$0.60-98.17% vs price
RSI (14)
27.6Oversold zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for NOTV

Inotiv, Inc. (NOTV) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.08, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 94.1% and below the 200-day moving average by 98.2%.

Momentum and stretch context

NOTV currently has an RSI reading of 27.6, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.

What traders may watch next

For traders reviewing NOTV next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Inotiv, Inc.

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Robert W. Leasure
Employees
2,027
Market cap
$2.8M
Beta
4.08
52-week range
$0.02 – $2.44
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
25 Nov 1997
ISIN
US45783Q1004
CUSIP
45783Q100
Website
inotiv.com
Company profile data from Financial Modeling Prep. NOTV listed on NASDAQ.
Share dilution

NOTV shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
34.7M
Since Jun 2019
+230.2%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. NOTV28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about NOTV

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.